Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>Ph+ * > Treatment > Co.: USA. P. Brand Bosutinib **

---

Co.: USA. P. Brand Bosutinib **'s subsections
(*) USA Approval Date: 2012. 09.04>
(*) USA Approval Date: 2017. 12.19>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2017. 08.29
TradeMark
TradeMark Web-Site

Co.: USA. P. Brand Bosutinib **'s products
This section has no products